Diabetes

Learn how high-dose metformin improves BMI, insulin needs, and LDL-C in adolescents with T1D.

New data suggests omega-3 supplements provide little to no benefit for diabetic polyneuropathy.

GLP-1RA use lowered cardiovascular, kidney, and mortality risks in patients with lupus and diabetes

Learn how low-dose ATG may preserve β-cell function in young people with recent-onset Type 1 diabetes.

Understand how GLP-1 receptor agonists may reduce fracture risk and improve bone density in Type 2 diabetes

Learn how tirzepatide treatment improves diet-related quality of life and satisfaction in Type 2 diabetes patients.

A global study covering 204 countries found that fewer than one in four people with diabetes achieved optimal glycaemic control, highlighting persistent gaps in diagnosis and treatment despite improvements since 2000.

Appropriate risk assessment before prescribing treatment, along with personalised management strategies, could help reduce the long-term burden of cardiometabolic diseases in this population.